Jeffrey Sherman
Board Member
Xeris Biopharma Holdings, Inc. (XERS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-01–present
-
Current
-
2021-01-01–2026-04-20
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Neogenomics Inc (NEO) | Chief Financial Officer | $603,731 | $4,681,428 |
| 2024 | Neogenomics Inc (NEO) | Chief Financial Officer | $540,346 | $3,482,409 |
| 2023 | Neogenomics Inc (NEO) | Chief Financial Officer | $525,000 | $3,547,358 |
| 2022 | Neogenomics Inc (NEO) | Chief Financial Officer | $16,154 | $3,266,154 |
| 2021 | Neogenomics Inc (NEO) | Chief Financial Officer | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.